Tag: Biparatopic Antibody
-
How Ziihera Targets HER2 Differently From Trastuzumab
Ziihera binds two HER2 extracellular domains simultaneously, promoting receptor internalization and immune-mediated killing through a mechanism distinct from trastuzumab and Enhertu.